Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries CVS Health Corp (NY: CVS ) 55.54 -1.53 (-2.68%) Official Closing Price Updated: 7:00 PM EST, Nov 8, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about CVS Health Corp < Previous 1 2 3 4 5 6 7 8 9 ... 48 49 Next > Stocks Rise, Netflix Soars To Record Highs, Oil Falls Below $70, Gold Miners Rally: What's Driving Markets Friday? October 18, 2024 Wall Street was in positive territory in Friday midday trading, buoyed by upbeat quarterly earnings reports that kept investor sentiment bullish. Via Benzinga Crude Oil Down Over 1%; American Express Shares Fall After Q3 Results October 18, 2024 Via Benzinga Exposures Fossil Fuels Elevance, CVS, UnitedHealth Struggle With Rising Medical Costs After COVID-19 Medicaid Policy Ends October 18, 2024 Insurers have reported higher medical costs due to the end of pandemic-era policies. States redetermining Medicaid eligibility created a disparity for insurers. Via Benzinga Exposures COVID-19 CVS Health Cuts Outlook, Joins American Express And Other Big Stocks Moving Lower In Friday's Pre-Market Session October 18, 2024 Via Benzinga CVS Health Unusual Options Activity For October 17 October 17, 2024 Via Benzinga What the Options Market Tells Us About CVS Health October 10, 2024 Via Benzinga US Stocks Set To End Week Strong As Netflix Q3 Earnings Boost Optimism, Gold Hits New Highs: What's Driving Sentiment Friday? October 18, 2024 Wall Street is priming for a positive start on Friday after the major averages ended narrowly mixed in the previous session. Via Benzinga Pharmacy Retailer CVS Health Backs Away From Annual Forecast, Names New CEO October 18, 2024 CVS Health replaces CEO Karen Lynch with David Joyner as the company struggles with lower earnings projections and rising medical costs. Q3 2024 results, including a $1.1 billion charge, are expected... Via Benzinga Amazon's Latest Healthcare Move Could Be a Big Problem for Walgreens and CVS October 17, 2024 Amazon looks to significantly ramp up its online pharmacy business. Via The Motley Fool Why CVS Health Stock Is Trading Lower October 15, 2024 CVS Health shares are trading lower by 3.8% during Tuesday's session. Health insurer stocks are down after UnitedHealth reported Q3 results and cut its annual EPS outlook. Via Benzinga Looking Into CVS Health's Recent Short Interest October 07, 2024 Via Benzinga Looking At CVS Health's Recent Unusual Options Activity October 07, 2024 Via Benzinga Unpacking the Latest Options Trading Trends in CVS Health October 02, 2024 Via Benzinga CVS Health: Are Its Parts Worth More Than the Whole? October 15, 2024 CVS Health Co. (NYSE: CVS) transformed from one of the largest drug store pharmacy chains in the country to an integrated healthcare company Via MarketBeat Welcome To The “Pain Trade” - Here’s What To Do About It October 14, 2024 The market is grinding higher, satisfying pretty much nobody. The bulls are left wanting more, whereas the bears who were short the market are forced to cover. Via Talk Markets Troubled Victoria’s Secret stock could surge by 72% October 13, 2024 Victoria’s Secret (VSCO) stock has stabilized in the past few weeks as investors focus on the recent leadership transition and the ongoing turnaround. Via Talk Markets Wall Street's Top 10 Stock Calls This Week - Saturday, Oct. 12 October 12, 2024 What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of Oct. 7-11, 2024. Via Talk Markets Where Does Hims & Hers Stock Go From Here? October 12, 2024 Is Hims & Hers in trouble since the FDA put a time clock on some GLP-1s, or is the future still bright? Via The Motley Fool Exposures Product Safety CVS Has 'Real Value,' Jim Cramer Says: Micron Had An 'Amazing' Quarter October 11, 2024 Via Benzinga CVS Health Positioned For Medicare Margin Expansion And Market Share Gains, Says Barclays Analyst October 10, 2024 Barclays upgrades CVS Health to Overweight, citing gains in pharmacy market share and potential upside from CostVantage. CVS is expected to recover 200 basis points in Medicare margins by 2026,... Via Benzinga This Nike Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday October 10, 2024 Via Benzinga Bernie Sanders And AOC Clap Back At Mark Cuban's Push for FCC Chief Shakeup: 'Anyone Goes Near Lina Khan And There Will Be An Out And Out Brawl' October 09, 2024 Alexandria Ocasio-Cortez and Bernie Sanders have strongly defended FTC chief Lina Khan and opposed Mark Cuban's suggestions that she be replaced if Kamala Harris becomes president. Via Benzinga Exposures Regulatory CVS, UnitedHealth Request FTC Chair Recusal Amid Ongoing Pharmacy Benefit Managers Lawsuit October 09, 2024 The FTC has filed a formal complaint accusing CVS, Cigna, and UnitedHealth of engaging in anti-competitive practices that inflate insulin prices. The complaint claims the PBMs' focus on rebates raises... Via Benzinga Biotech Stocks Poised For Another Big Move In Q4 October 07, 2024 The healthcare sector can be a safe haven if volatility increases. Via Talk Markets Does This New Development Make CVS Stock a Buy or a Sell? October 06, 2024 Major changes could soon be coming, but will they drive the stock up? Via The Motley Fool Billionaire Investor Pushes for Changes at CVS. Is Now the Time to Buy the Stock? October 05, 2024 The stock could be poised for a turnaround. Via The Motley Fool An Activist Investor Is Interested in CVS; We Take a Look October 04, 2024 We also chat about Uber and its quest to become an everything app. Via The Motley Fool This Morgan Stanley Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday October 04, 2024 Via Benzinga Domino's Pizza To Rally Over 38%? Here Are 10 Top Analyst Forecasts For Friday October 04, 2024 Via Benzinga Texas Attorney General Sues Insulin Manufacturers and Pharmacy Benefit Managers Over Price-Fixing Conspiracy That Increased Prices by 1,000% October 03, 2024 Texas Attorney General Ken Paxton sues major insulin manufacturers and PBMs, accusing them of conspiring to inflate insulin prices by as much as 1,000%, violating Texas law and harming diabetes... Via Benzinga Topics Lawsuit Exposures Financial Legal < Previous 1 2 3 4 5 6 7 8 9 ... 48 49 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
